Institut Pasteur de Dakar

Research Services • Dakar, Dakar Region, Senegal • 501-1000 Employees

Company overview

Headquarters	36, Avenue Pasteur, Dakar, Dakar 12900, SN
Phone number	+221338399233
Websites	pasteur.sn institutpasteurdakar.sn
NAICS	5417
Keywords	Analyses Biologiques, Analyse Biomédicale, Analyses Eaux Aliments Environnement, Production De Vaccins, Recherche Et Santé Publique, Vaccination Et Traitement Rage
Founded	1924
Employees	501-1000
Socials

Key Contacts at Institut Pasteur de Dakar

Dr Ibrahima Socé Fall

Chief Executive Officer

Xavier Berthet

Director - Biomedical Research

Mohamed Ndiaye

Director Du

Patrick Eloundou

Director Of Operations, Africamaril Manufacturing Plant Of Yellow Fever Vaccine

Omar Gueye

Director Of Production Operations

Sophie Ndiaye Diouf

Chief Commercial & Business Development Officer, Director

Lamine Sene

Site Director

Institut Pasteur de Dakar Email Formats

Institut Pasteur de Dakar uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@pasteur.sn), used 82.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@pasteur.sn	82.9%
{first initial}.{last name}	j.doe@pasteur.sn	10.5%
{first initial}{last name}	jdoe@pasteur.sn	1.8%
{first name}{last name}	johndoe@pasteur.sn	1.2%

About Institut Pasteur de Dakar

IPD is a Senegalese not-for-profit foundation working to advance equitable access to healthinAfrica, especially in Senegal. We do this by providing communities with Healthcare Solutions and Laboratory services, engaging in cutting-edge Biomedical Research and Innovation, manufacturing Vaccines and Diagnostics essential to African populations, developing Human Capital, and engaging in Public Health activities such as epidemic intelligence, outbreak response, and surveillance. In a unique and innovative way, IPD brings together key capabilities and functions to address public health challenges in Africa. IPD plays an important regional role through its various specialized reference laboratories and its partnership with WHO in the fight against infectious diseases. IPD is one of the four WHO prequalified manufacturers to supply yellow fever vaccines to UN Agencies.

Institut Pasteur de Dakar revenue & valuation

Annual revenue	$46,700,000
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$149,300,000
Total funding	$45,000,000

Employees by Management Level

Total employees: 501-1000

Seniority

Employees

Entry

Manager

Intern

Employees by Department

Institut Pasteur de Dakar has 238 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Institut Pasteur de Dakar's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-01-13	12	$45,000,000

Funding Insights

$45,000,000

Total funding amount

$45,000,000

Most recent funding amount

Number of funding rounds

Institut Pasteur de Dakar Tech Stack

Discover the technologies and tools that power Institut Pasteur de Dakar's digital infrastructure, from frameworks to analytics platforms.

Material Design Lite

UI frameworks

Site Kit

Analytics

Animate.css

UI frameworks

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

anime.js

JavaScript graphics

Google Analytics

Analytics

Yoast SEO

SEO

Google Tag Manager

Tag managers

Frequently asked questions

Institut Pasteur de Dakar is located in Dakar, Dakar Region, SN.

You can reach Institut Pasteur de Dakar at +221338399233.

Institut Pasteur de Dakar was founded in 1924, making it 102 years old. The company has established itself as a significant player in its industry over this time.

Institut Pasteur de Dakar has approximately 501-1000 employees. The company continues to grow its workforce to support its business operations and expansion.

Institut Pasteur de Dakar has raised a total of $45,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.